FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40121711000001100: Bupivacaine liposomal (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2042371000001116 Bupivacaine liposomal en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2042381000001119 Bupivacaine liposomal (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bupivacaine liposomal Is a Anesthetic true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bupivacaine liposomal 133mg/10ml prolonged-release dispersion for injection vials Has specific active ingredient True Bupivacaine liposomal Inferred relationship Existential restriction modifier
Bupivacaine liposomal 266mg/20ml prolonged-release dispersion for injection vials Has specific active ingredient True Bupivacaine liposomal Inferred relationship Existential restriction modifier
Bupivacaine liposomal 133mg/10ml prolonged-release dispersion for injection vials 10 vial Has specific active ingredient True Bupivacaine liposomal Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Has specific active ingredient True Bupivacaine liposomal Inferred relationship Existential restriction modifier
Bupivacaine liposomal 266mg/20ml prolonged-release dispersion for injection vials 10 vial Has specific active ingredient True Bupivacaine liposomal Inferred relationship Existential restriction modifier
Exparel liposomal 133mg/10ml prolonged-release dispersion for injection vials (Pacira Ltd) Has specific active ingredient True Bupivacaine liposomal Inferred relationship Existential restriction modifier
Exparel liposomal 133mg/10ml prolonged-release dispersion for injection vials (Pacira Ltd) 10 vial Has specific active ingredient True Bupivacaine liposomal Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) 10 vial Has specific active ingredient True Bupivacaine liposomal Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start